Kite Pharma is ... hematology and oncology therapeutics as well as more than two years spent leading Amgen’s Canadian operations; he closed out his time at the company as VP and general manager ...

Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all ...